Showing results (201-210 of 223) with videos related to
Sort By:
Pageof 23
British Journal of Cancer|November 11, 2017
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancerJordi Codony-Servat, Miriam Cuatrecasas, Elena Asensio, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trialMiguel Martín, Alvaro Rodriguez-Lescure, Cristina Reboredo, et al.The Journal of Molecular Diagnostics : JMD|July 1, 2018
Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal CancerIván Prieto-Potin, Clara Montagut, Beatriz Bellosillo, et al.Cancer Research|March 3, 2017
Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast CancerJuan M Cejalvo, Eduardo Martínez de Dueñas, Patricia Galván, et al.The Journal of Clinical Investigation|June 24, 2020
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic diseaseSusana Garcia-Recio, Aatish Thennavan, Michael P East, et al.Cancer Cell|July 11, 2025
TIM3+ breast cancer cells license immune evasion during micrometastasis outbreakCatalina Rozalén, Irene Sangrador, Silvia Avalle, et al.Cell Reports. Medicine|June 21, 2025
MET pathway inhibition increases chemo-immunotherapy efficacy in small cell lung cancerRaúl Del Rey-Vergara, Miguel Alejandro Galindo-Campos, Pedro Rocha, et al.Nature Communications|July 26, 2018
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancerAurélie S Cazet, Mun N Hui, Benjamin L Elsworth, et al.Oncotarget|April 21, 2017
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancerAranzazu Fernandez-Martinez, Tomás Pascual, Giuseppe Perrone, et al.Virchows Archiv : an International Journal of Pathology|April 7, 2026
Homologous recombination deficiency tumor tissue testing in a real-world cohort of tubo-ovarian carcinoma patients: validation of decentralized genomic profiling in 4777 casesFederico Rojo, Conxi Lazaro, Ihab Abdulkader-Nallib, et al.Pageof 23